FDA Drug Application (208056) for DEXILANT SOLUTAB by TAKEDA PHARMS USA

Back to FDA Applications sponsored by TAKEDA PHARMS USA

Application Number208056
Product Number001
FormTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
Dosage30MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDEXILANT SOLUTAB
Active IngredientDEXLANSOPRAZOLE

Active IngredientCount
List of drugs with Active Ingredient DEXLANSOPRAZOLE3


Back to FDA Applications sponsored by TAKEDA PHARMS USA